Continuous infusion epidural analgesia in parturients receiving bupivacaine, chloroprocaine, or lidocaine--maternal, fetal, and neonatal effects
- PMID: 6703368
Continuous infusion epidural analgesia in parturients receiving bupivacaine, chloroprocaine, or lidocaine--maternal, fetal, and neonatal effects
Abstract
The effects of epidural analgesia for labor and delivery using a continuous infusion technique on fetal heart rate, uterine activity, maternal blood pressure, Apgar scores, neonatal acid-base status, and the Neurologic and Adaptive Capacity Scoring System were studied in 61 parturients. Group I (n = 23) received initial test and therapeutic doses of 2 and 6 ml of 0.5% bupivacaine followed by an infusion of 0.125% at a rate of 14 ml/hr. Group II (n = 19) received 2 and 6 ml of 2% chloroprocaine followed by an infusion of 0.75% at a rate of 27 ml/hr. Group III (n = 19) received 2 and 6 ml of 1.5% lidocaine followed by an infusion of 0.75% at a rate of 14 ml/hr. None of the three local anesthetics used had any significant effect on baseline fetal heart rate or uterine activity. In cases in which monitoring of fetal heart rate was both technically satisfactory and continuous, late and variable decelerations in fetal heart rate were seen in 10 of 17, 3 of 18, and 2 of 19 of the fetuses in groups I, II, and III, respectively. The incidence was significantly higher in group I than in groups II or III (P less than 0.05). Apgar scores and neonatal acid-base status were equally good in all three groups. Neurologic and adaptive capacity scores did not differ among the three groups of neonates, nor did any of the neonates in the three groups score lower than a control group of 19 neonates whose mothers did not receive any analgesia or medications for labor and delivery.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Maternal, fetal, and neonatal responses after epidural anesthesia with bupivacaine, 2-chloroprocaine, or lidocaine.Anesth Analg. 1982 Aug;61(8):638-44. Anesth Analg. 1982. PMID: 7201266
-
Maternal, fetal, and neonatal effects of lidocaine with and without epinephrine for epidural anesthesia in obstetrics.Anesth Analg. 1984 Nov;63(11):973-9. Anesth Analg. 1984. PMID: 6496982
-
Comparative maternal, fetal, and neonatal effects of chloroprocaine with and without epinephrine for epidural anesthesia in obstetrics.Anesth Analg. 1987 Jan;66(1):71-5. Anesth Analg. 1987. PMID: 3099600
-
Obstetric medication and neonatal behavior. Current controversies.Clin Perinatol. 1985 Jun;12(2):423-40. Clin Perinatol. 1985. PMID: 3893844 Review.
-
Fetal and neonatal effects of epidural anesthesia.Obstet Gynecol Annu. 1985;14:240-52. Obstet Gynecol Annu. 1985. PMID: 3885092 Review. No abstract available.
Cited by
-
Update on obstetrical anaesthesia.Can Anaesth Soc J. 1986 Mar;33(2):238-45. doi: 10.1007/BF03010839. Can Anaesth Soc J. 1986. PMID: 3516336 Review. No abstract available.
-
Placental transfer of lidocaine hydrochloride after prolonged continuous maternal intravenous administration.Can J Anaesth. 1995 Apr;42(4):338-40. doi: 10.1007/BF03010711. Can J Anaesth. 1995. PMID: 7788831
-
Adverse effects and drug interactions associated with local and regional anaesthesia.Drug Saf. 1998 Apr;18(4):221-50. doi: 10.2165/00002018-199818040-00001. Drug Saf. 1998. PMID: 9565736 Review.
-
Circulatory stability and plasma lidocaine levels during continuous and intermittent thoracic epidural analgesia.J Anesth. 1991 Apr;5(2):166-71. doi: 10.1007/s0054010050166. J Anesth. 1991. PMID: 15278651
-
Maternal positioning affects fetal heart rate changes after epidural analgesia for labour.Can J Anaesth. 1993 Dec;40(12):1136-41. doi: 10.1007/BF03009602. Can J Anaesth. 1993. PMID: 8281589 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical